NO944838D0 - Arabinogalaktanderivater og anvendelser derav - Google Patents
Arabinogalaktanderivater og anvendelser deravInfo
- Publication number
- NO944838D0 NO944838D0 NO944838A NO944838A NO944838D0 NO 944838 D0 NO944838 D0 NO 944838D0 NO 944838 A NO944838 A NO 944838A NO 944838 A NO944838 A NO 944838A NO 944838 D0 NO944838 D0 NO 944838D0
- Authority
- NO
- Norway
- Prior art keywords
- arabinogalactan derivatives
- arabinogalactan
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/605—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the macromolecule containing phosphorus in the main chain, e.g. poly-phosphazene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1992/005091 WO1993025239A1 (en) | 1992-06-17 | 1992-06-17 | Arabinogalactan derivatives and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO944838D0 true NO944838D0 (no) | 1994-12-14 |
NO944838L NO944838L (no) | 1995-02-17 |
Family
ID=4154623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944838A NO944838L (no) | 1992-06-17 | 1994-12-14 | Arabinogalaktanderivater og anvendelser derav |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0646018A1 (no) |
JP (1) | JPH07507794A (no) |
CA (1) | CA2135295A1 (no) |
NO (1) | NO944838L (no) |
WO (1) | WO1993025239A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490991A (en) * | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5728518A (en) * | 1994-01-12 | 1998-03-17 | The Immune Response Corporation | Antiviral poly-and oligonucleotides |
FR2716625B1 (fr) * | 1994-02-25 | 1996-04-26 | Gouchet Franck Arno | Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non. |
US5567685A (en) * | 1994-08-16 | 1996-10-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Water-Soluble polyene conjugate |
US5897987A (en) | 1996-03-25 | 1999-04-27 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
US6303584B1 (en) | 1996-11-20 | 2001-10-16 | The University Of Montana | Water soluble lipidated arabinogalactan |
US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
DK0973928T3 (da) | 1997-03-11 | 2010-08-09 | Univ Minnesota | DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle |
US6929936B1 (en) * | 1997-07-18 | 2005-08-16 | Danisco A/S | Composition comprising an enzyme having galactose oxidase activity and use thereof |
JP4873513B2 (ja) * | 1998-04-27 | 2012-02-08 | ロンザ,インコーポレイティド | アラビノガラクタンの誘導体類及びそれらを含む組成物 |
US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
IL131074A0 (en) * | 1999-07-23 | 2001-03-19 | Polygene Ltd | A biodegradable polycation composition for delivery of an anionic macromolecule |
EP1286699A2 (en) * | 2000-05-19 | 2003-03-05 | Regents Of The University Of Minnesota | Composition for delivery of compounds to cells |
AU2003231048A1 (en) | 2002-04-22 | 2003-11-03 | Regents Of The University Of Minnesota | Transposon system and methods of use |
ITMI20040928A1 (it) | 2004-05-07 | 2004-08-07 | Uni Di Bologna Dipartiment O D | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
ITMI20051743A1 (it) * | 2005-09-20 | 2007-03-21 | Uni Di Bologna Dipartimento Di Patologia Spa | Uso di coniugati della doxorubicina con albumina lattosaminata |
RU2359975C2 (ru) * | 2007-04-04 | 2009-06-27 | Институт нефтехимии и катализа РАН | Способ получения модифицированных арабиногалактанов |
CN102399238B (zh) * | 2011-12-21 | 2013-06-12 | 开封明仁药业有限公司 | 氨磷汀的制备方法 |
RU2521649C1 (ru) * | 2013-03-04 | 2014-07-10 | Федеральное Государственное Бюджетное Учреждение Науки Институт Химии И Химической Технологии Сибирского Отделения Российской Академии Наук (Иххт Со Ран) | Способ получения сульфатированных производных арабиногалактана |
WO2014176389A1 (en) * | 2013-04-24 | 2014-10-30 | Temple University - Of The Commonwealth System Of Higher Education | Solid dosage form containing arabinogalactan |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3200766A1 (de) * | 1981-01-14 | 1982-09-16 | Toyo Jozo Kk | Praeparat mit ausgezeichneter absorptionseigenschaft |
JPH0816118B2 (ja) * | 1988-02-03 | 1996-02-21 | 呉羽化学工業株式会社 | 抗ウイルス剤 |
EP0381742B1 (en) * | 1988-08-04 | 1996-06-19 | Advanced Magnetics Incorporated | Receptor mediated endocytosis type mri contrast agents |
-
1992
- 1992-06-17 JP JP6501422A patent/JPH07507794A/ja active Pending
- 1992-06-17 CA CA002135295A patent/CA2135295A1/en not_active Abandoned
- 1992-06-17 EP EP92914217A patent/EP0646018A1/en not_active Withdrawn
- 1992-06-17 WO PCT/US1992/005091 patent/WO1993025239A1/en not_active Application Discontinuation
-
1994
- 1994-12-14 NO NO944838A patent/NO944838L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH07507794A (ja) | 1995-08-31 |
CA2135295A1 (en) | 1993-12-23 |
EP0646018A1 (en) | 1995-04-05 |
NO944838L (no) | 1995-02-17 |
WO1993025239A1 (en) | 1993-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961425D0 (no) | 1N-alkyl-N-arylpyrimidinaminer og derivater derav | |
DE59208263D1 (de) | 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate | |
FI961599A (fi) | 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia | |
NO944838D0 (no) | Arabinogalaktanderivater og anvendelser derav | |
BR1100824A (pt) | Composto e composição farmacêutica | |
NO922291D0 (no) | 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater | |
ATA75293A (de) | Indolderivate | |
IT1266582B1 (it) | Derivati (di)azacicloesanici e diazacicloeptanici | |
ITMI920408A1 (it) | Derivati benzopiranici e benzotiopiranici | |
NO943763D0 (no) | 4-arylamino-benzopyraner og beslektede forbindelser | |
DK0804078T3 (da) | Sammensætning og anvendelse deraf | |
DE69330497D1 (de) | Chinazolin-derivate | |
DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
EP0482649A3 (en) | Cm-chitin derivatives and use thereof | |
DK0821692T3 (da) | Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf | |
NO922934D0 (no) | Cykloheksan- og tetrahydropyranderivater | |
NO952288D0 (no) | Benzazepinon-derivater | |
DE69313890T2 (de) | 5-Aminoflavon-Derivate | |
IS4140A (is) | Notkun á ferróseni og/eða ferrósenafleiðum | |
FI1031U1 (fi) | En troakar | |
ITMI921571A1 (it) | Azaciclo e azabiciclo alchiliden idrossilamine | |
BR9205281A (pt) | Pentapeptideos imuno-reguladores e neuro-reguladores | |
DE59407726D1 (de) | 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate | |
PT8772T (pt) | Recipiente-embalagem e brinquedo | |
NO930418D0 (no) | Innstikkbar helletut |